Cargando…
Docetaxel-Aggravated Psoriasis
Autores principales: | Yang, Seungkeol, Kim, Bo Ri, Choi, Chong Won, Youn, Sang Woong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Dermatological Association; The Korean Society for Investigative Dermatology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992687/ https://www.ncbi.nlm.nih.gov/pubmed/33911581 http://dx.doi.org/10.5021/ad.2019.31.2.240 |
Ejemplares similares
-
Economic Factors as Major Determinants of Ustekinumab Drug Survival of Patients with Chronic Plaque Psoriasis in Korea
por: Choi, Chong Won, et al.
Publicado: (2018) -
Risk Factors Affecting Adverse Effects of Cyclosporine A in a Real-World Psoriasis Treatment
por: Kim, Bo Ri, et al.
Publicado: (2018) -
Toenail Psoriasis during Ustekinumab Therapy: Results and Limitations
por: Yang, Seungkeol, et al.
Publicado: (2021) -
Methotrexate in a Real-World Psoriasis Treatment: Is It Really a Dangerous Medication for All?
por: Kim, Bo Ri, et al.
Publicado: (2017) -
Morphological Characteristics of Psoriatic Lesions Affect the Accuracy and Reliability of Severity Assessments: Proposal for New Working Criteria for the Psoriasis Area and Severity Index
por: Choi, Chong Won, et al.
Publicado: (2019)